Erratum: Evidence for G-quadruplex in the promoter of VEGFR-2 and its targeting to inhibit tumor angiogenesis (Nucleic Acids Research (2014) 42:5 (2945-57) DOI: 10.1093/nar/gkt1289);Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis

Nucleic Acids Research

Volumn 42, Issue 5, 2014, Pages 2945-2957

  Salvati, Erica ^a   Zizza, Pasquale ^a   Rizzo, Angela ^a   Iachettini, Sara ^a   Cingolani, Chiara ^a   D'angelo, Carmen ^a   Porru, Manuela ^a   Randazzo, Antonio ^b   Pagano, Bruno ^b   Novellino, Ettore ^b   Pisanu, Maria Elena ^c   Stoppacciaro, Antonella ^c   Spinella, Francesca ^a   Bagnato, Anna ^a   Gilson, Eric ^d,e   Leonetti, Carlo ^a   Biroccio, Annamaria ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE QUADRUPLEX; VASCULOTROPIN RECEPTOR 2;

ACTIN FILAMENT; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; VEGFR 2 GENE;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; G-QUADRUPLEXES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIGANDS; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84898954191     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1217     Document Type: Erratum

References (55)

1. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1, 27-31.
2. Liotta, L.A., Kleinerman, J. and Saidel, G.M. (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res., 34, 997-1004.
3. Folkman, J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Natl Cancer Inst., 82, 4-6. (Pubitemid 20020880
4. Bergers, G. and Benjamin, L.E. (2003) Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer, 3, 401-410.
5. Martiny-Baron, G. and Marme, D. (1995) VEGF-mediated tumour angiogenesis: A new target for cancer therapy. Curr. Opin. Biotechnol., 6, 675-680.
6. Folkman, J. (2002) Role of angiogenesis in tumor growth and metastasis. Semin. Oncol., 29, 15-18.
7. Jain, R.K. (2002) Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor. Semin. Oncol., 29, 3-9.
8. Rifkin, D.B. and Moscatelli, D. (1989) Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol., 109, 1-6. (Pubitemid 19180114
9. Gleave, M.E., Hsieh, J.T., Wu, H.C., Hong, S.J., Zhau, H.E., Guthrie, P.D. and Chung, L.W. (1993) Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res., 53, 5300-5307. (Pubitemid 23333403
10. Nicosia, R.F., Nicosia, S.V. and Smith, M. (1994) Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am. J. Pathol., 145, 1023-1029.
11. Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C. et al. (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-Trap expression cloning. Cell, 87, 1161-1169. (Pubitemid 27010100
12. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N. et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 277, 55-60. (Pubitemid 27450643
13. Inoue, M., Hager, J.H., Ferrara, N., Gerber, H.P. and Hanahan, D. (2002) VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell, 1, 193-202. (Pubitemid 41039165
14. Mustonen, T. and Alitalo, K. (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol., 129, 895-898.
15. Ferrara, N., Gerber, H.P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med., 9, 669-676.
16. Shibuya, M. and Claesson-Welsh, L. (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res., 312, 549-560.
17. Olsson, A.K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol., 7, 359-371.
18. Heasman, S.J. and Ridley, A.J. (2008) Mammalian Rho GTPases: New insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol., 9, 690-701.
19. Sitohy, B., Nagy, J.A. and Dvorak, H.F. (2012) Anti-VEGF/ VEGFR therapy for cancer: Reassessing the target. Cancer Res., 72, 1909-1914.
20. Han, H. and Hurley, L.H. (2000) G-quadruplex DNA: A potential target for anti-cancer drug design. Trends Pharmacol. Sci., 21, 136-142.
21. Kelland, L. (2007) Targeting the limitless replicative potential of cancer: The telomerase/telomere pathway. Clin. Cancer Res., 13, 4960-4963.
22. Neidle, S. (2010) Human telomeric G-quadruplex: The current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J., 277, 1118-1125.
23. Balasubramanian, S., Hurley, L.H. and Neidle, S. (2011) Targeting G-quadruplexes in gene promoters: A novel anticancer strategy? Nat. Rev. Drug. Discov., 10, 261-275.
24. Biffi, G., Tannahill, D., McCafferty, J. and Balasubramanian, S. (2013) Quantitative visualization of DNA G-quadruplex structures in human cells. Nat. Chem., 5, 182-186.
25. Lam, E.Y., Beraldi, D., Tannahill, D. and Balasubramanian, S. (2013) G-quadruplex structures are stable and detectable in human genomic DNA. Nat. Commun., 4, 1796.
26. Salvati, E., Leonetti, C., Rizzo, A., Scarsella, M., Mottolese, M., Galati, R., Sperduti, I., Stevens, M.F., D'Incalci, M., Blasco, M. et al. (2007) Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J. Clin. Invest., 117, 3236-3247.
27. Mammoto, A., Connor, K.M., Mammoto, T., Yung, C.W., Huh, D., Aderman, C.M., Mostoslavsky, G., Smith, L.E. and Ingber, D.E. (2009) A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature, 457, 1103-1108.
28. Siddiqui-Jain, A., Grand, C.L., Bearss, D.J. and Hurley, L.H. (2002) Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc. Natl Acad. Sci. USA, 99, 11593-11598.
29. Biroccio, A., Benassi, B., Filomeni, G., Amodei, S., Marchini, S., Chiorino, G., Rotilio, G., Zupi, G. and Ciriolo, M.R. (2002) Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells. J. Biol. Chem., 277, 43763-43770.
30. Zhang, J., Lu, A., Beech, D., Jiang, B. and Lu, Y. (2007) Suppression of breast cancer metastasis through the inhibition of VEGFmediated tumor angiogenesis. Cancer Ther., 5, 273-286.
31. Sander, E.E., ten Klooster, J.P., van Delft, S., van der Kammen, R.A. and Collard, J.G. (1999) Rac downregulates Rho activity: Reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol., 147, 1009-1022.
32. Leonetti, C., Scarsella, M., Riggio, G., Rizzo, A., Salvati, E., D'Incalci, M., Staszewsky, L., Frapolli, R., Stevens, M.F., Stoppacciaro, A. et al. (2008) G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors. Clin. Cancer Res., 14, 7284-7291.
33. Kikin, O., D'Antonio, L. and Bagga, P.S. (2006) QGRS Mapper: A web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res., 34, W676-W682. (Pubitemid 44529856
34. Masiero, S., Trotta, R., Pieraccini, S., De Tito, S., Perone, R., Randazzo, A. and Spada, G.P. (2010) A non-empirical chromophoric interpretation of CD spectra of DNA Gquadruplex structures. Org. Biomol. Chem., 8, 2683-2692.
35. Karsisiotis, A.I., Hessari, N.M., Novellino, E., Spada, G.P., Randazzo, A. and Webba da Silva, M. (2011) Topological characterization of nucleic acid G-quadruplexes by UV absorption and circular dichroism. Angew. Chem. Int. Ed. Engl., 50, 10645-10648.
36. Randazzo, A., Spada, G.P. and da Silva, M.W. (2013) Circular dichroism of quadruplex structures. Top. Curr. Chem., 330, 67-86.
37. Pagano, B., Cosconati, S., Gabelica, V., Petraccone, L., De Tito, S., Marinelli, L., La Pietra, V., di Leva, F.S., Lauri, I., Trotta, R. et al. (2012) State-of-The-Art methodologies for the discovery and characterization of DNA G-quadruplex binders. Curr. Pharm. Des., 18, 1880-1899.
38. Leonetti, C., Amodei, S., D'Angelo, C., Rizzo, A., Benassi, B., Antonelli, A., Elli, R., Stevens, M.F., D'Incalci, M., Zupi, G. et al. (2004) Biological activity of the G-quadruplex ligand RHPS4 (3, 11-difluoro-6, 8, 13-Trimethyl-8H-quino[4, 3, 2-kl]acridinium methosulfate) is associated with telomere capping alteration. Mol. Pharmacol., 66, 1138-1146.
39. Gowan, S.M., Heald, R., Stevens, M.F. and Kelland, L.R. (2001) Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. Mol. Pharmacol., 60, 981-988.
40. Lamalice, L., Le Boeuf, F. and Huot, J. (2007) Endothelial cell migration during angiogenesis. Circ. Res., 100, 782-794.
41. Casagrande, V., Salvati, E., Alvino, A., Bianco, A., Ciammaichella, A., D'Angelo, C., Ginnari-Satriani, L., Serrilli, A.M., Iachettini, S., Leonetti, C. et al. (2011) N-cyclic bay-substituted perylene G-quadruplex ligands have selective antiproliferative effects on cancer cells and induce telomere damage. J. Med. Chem., 54, 1140-1156.
42. Franceschin, M., Rizzo, A., Casagrande, V., Salvati, E., Alvino, A., Altieri, A., Ciammaichella, A., Iachettini, S., Leonetti, C., Ortaggi, G. et al. (2012) Aromatic core extension in the series of N-cyclic bay-substituted perylene G-quadruplex ligands: Increased telomere damage, antitumor activity, and strong selectivity for neoplastic over healthy cells. ChemMedChem, 7, 2144-2154.
43. Beckers, C.M., van Hinsbergh, V.W. and van Nieuw Amerongen, G.P. (2010) Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost, 103, 40-55.
44. Connolly, J.O., Simpson, N., Hewlett, L. and Hall, A. (2002) Rac regulates endothelial morphogenesis and capillary assembly. Mol. Biol. Cell, 13, 2474-2485.
45. Sun, D., Guo, K., Rusche, J.J. and Hurley, L.H. (2005) Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents. Nucleic Acids Res., 33, 6070-6080. (Pubitemid 41742625
46. Sun, D., Guo, K. and Shin, Y.J. (2011) Evidence of the formation of G-quadruplex structures in the promoter region of the human vascular endothelial growth factor gene. Nucleic Acids Res., 39, 1256-1265.
47. Taka, T., Joonlasak, K., Huang, L., Randall Lee, T., Chang, S.W. and Tuntiwechapikul, W. (2012) Down-regulation of the human VEGF gene expression by perylene monoimide derivatives. Bioorg. Med. Chem. Lett., 22, 518-522.
48. De Armond, R., Wood, S., Sun, D., Hurley, L.H. and Ebbinghaus, S.W. (2005) Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter. Biochemistry, 44, 16341-16350. (Pubitemid 41785833
49. Lombardo, C.M., Welsh, S.J., Strauss, S.J., Dale, A.G., Todd, A.K., Nanjunda, R., Wilson, W.D. and Neidle, S. (2012) A novel series of G-quadruplex ligands with selectivity for HIF-expressing osteosarcoma and renal cancer cell lines. Bioorg. Med. Chem. Lett., 22, 5984-5988.
50. Qin, Y., Rezler, E.M., Gokhale, V., Sun, D. and Hurley, L.H. (2007) Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4. Nucleic Acids Res., 35, 7698-7713.
51. Viglasky, V. (2009) Platination of telomeric sequences and nuclease hypersensitive elements of human c-myc and PDGF-A promoters and their ability to form G-quadruplexes. FEBS J., 276, 401-409.
52. Qin, Y., Fortin, J.S., Tye, D., Gleason-Guzman, M., Brooks, T.A. and Hurley, L.H. (2010) Molecular cloning of the human plateletderived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expression. Biochemistry, 49, 4208-4219.
53. Chen, Y., Agrawal, P., Brown, R.V., Hatzakis, E., Hurley, L. and Yang, D. (2012) The major G-quadruplex formed in the human platelet-derived growth factor receptor beta promoter adopts a novel broken-strand structure in K+solution. J. Am. Chem. Soc., 134, 13220-13223.
54. Patterson, C., Perrella, M.A., Hsieh, C.M., Yoshizumi, M., Lee, M.E. and Haber, E. (1995) Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J. Biol. Chem., 270, 23111-23118.
55. Sun, D. and Hurley, L.H. (2010) Biochemical techniques for the characterization of G-quadruplex structures: EMSA, DMS footprinting, and DNA polymerase stop assay. Methods Mol. Biol., 608, 65-79.